@article{article, title  = {{2408TiP DISCUS: A randomised phase II study of 3 vs 6 cycles of chemotherapy followed by maintenance avelumab in advanced urothelial cancer - Wearable devices and circulating biomarkers assessing quality of life and surrogate efficacy endpoints}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.annonc.2023.09.2826 }},

 year = {{2023}},

 month = {{10}},

 author = {{Jackson-Spence F and Marin AP and Puente J and Molina-Cerrillo J and Hussain SA and Ackerman C and Bonsu N and Kelly J and Loriot Y and Powles TB and Pulido EG}},

 doi = {{10.1016/j.annonc.2023.09.2826}},

 volume = {{34}},

 journal = {{Annals of Oncology}},

 pages = {{S1224-S1225}},

 note = {{Accessed on 2024/12/22}}}